We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Regulation on Biosimilars Goes Into Effect in Mexico
New Regulation on Biosimilars Goes Into Effect in Mexico
Mexican regulators laid out rules for older biosimilars registered prior to Oct. 19, 2011, when the country’s biosimilarity rules were first established, mandating that companies conduct clinical trials to prove biosimilarity.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor